Gene Research

New web site offers online custom lentiviral vector design manufacturing services

Published in Gene Therapy Weekly, December 22nd, 2005

Lentigen Corporation, a privately owned biotechnology company manufacturing and developing research and therapeutic grade lentiviral vectors, announced the launch of a web site providing custom lentiviral vector manufacturing services for academic, government, biotechnology, and pharmaceutical researchers.

Lentiviral vectors are highly adapted delivery vehicles that can transport therapeutic genes into cells with high efficiency and stability. Utilizing its proprietary LentiMax vector, an HIV-1 based lentiviral vector system synthetically optimized for high titer and safety, Lentigen will manufacture custom lentiviral vectors. Alternatively, Lentigen can manufacture any...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-12-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry